Overview Dividends

(BRO) Brown & Brown - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1152361010

Insurance, Brokerage, Retail, Programs, Services

Insurance Brokers
Market Cap in USD: 27,867m

IPO / Inception: 1992-03-03
Return 12m vs S&P 500: -30.1%

EPS (Earnings per Share)

EPS CAGR: 27.68%
EPS Trend: 80.3%

Last SUE: 3.67
Qual. Beats: 2

Revenue

Rev. CAGR: 23.05%
Rev. Trend: 90.5%

Last SUE: 2.18
Qual. Beats: 1

Dividends

Dividend Yield	0.76%
Yield on Cost 5y	1.38%
Yield CAGR 5y	11.61%
Payout Consistency	93.0%
Payout Ratio	14.5%

Risk via 5d forecast
Volatility	20.6%
Value at Risk 5%th	32.6%
Relative Tail Risk	-3.95%

Reward TTM
Sharpe Ratio	-1.05
Alpha	-28.98
CAGR/Max DD	0.34

Character TTM
Hurst Exponent	0.459
Beta	0.321
Beta Downside	0.344

Drawdowns 3y
Max DD	38.27%
Mean DD	7.28%
Median DD	3.41%

Description: BRO Brown & Brown December 17, 2025

Brown & Brown, Inc. (NYSE:BRO) is a diversified insurance intermediary that sells a broad range of property-and-casualty, employee-benefits, and specialty insurance products across the United States, Canada, Ireland, the United Kingdom, and other international markets.

The Retail segment delivers direct insurance solutions-including personal lines, commercial P&C, and risk-management services-to commercial, public-sector, professional, and individual clients, handling everything from underwriting to claims processing.

The Programs segment focuses on niche professional-liability packages for dentists, lawyers, physicians, real-estate title professionals, and related fields, as well as supplemental coverages for weddings, events, cyber risk, and medical facilities, often distributed through independent agents.

The Wholesale Brokerage segment markets excess and surplus lines for both commercial and personal lines, leveraging a network of independent brokers to place high-limit and specialty risks that primary carriers typically avoid.

The Services segment provides outsourced claims administration, medical-utilization management, Medicare Set-Aside, Social Security disability advocacy, and adjusting services across workers’-compensation and all-lines liability exposures.

From a financial-performance perspective, Brown & Brown reported FY 2023 written premiums of roughly $9.7 billion-a 5 % year-over-year increase-while its combined ratio improved to 94.5 %, reflecting tighter underwriting discipline. The firm’s investment income benefited from a 5 % average U.S. Treasury yield, underscoring the sensitivity of insurers’ bottom lines to interest-rate environments. A key sector driver is the accelerating demand for cyber-liability coverage, which has been a primary source of premium growth for the Programs and Wholesale segments.

For a deeper, data-driven look at BRO’s valuation metrics and scenario analysis, you might find ValueRay’s platform worth a quick glance.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (999.0m TTM) > 0 and > 6% of Revenue (6% = 319.7m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA -1.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 23.51% (prev 20.97%; Δ 2.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 1.37b > Net Income 999.0m (YES >=105%, WARN >=100%)

Net Debt (-3.14b) to EBITDA (1.88b) ratio: -1.67 <= 3.0 (WARN <= 3.5)

Current Ratio 1.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (332.0m) change vs 12m ago 17.31% (target <= -2.0% for YES)

Gross Margin 49.35% (prev 47.76%; Δ 1.59pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 22.74% (prev 25.96%; Δ -3.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 6.24 (EBITDA TTM 1.88b / Interest Expense TTM 255.0m) >= 6 (WARN >= 3)

Altman Z'' 1.92

(A) 0.04 = (Total Current Assets 8.14b - Total Current Liabilities 6.89b) / Total Assets 29.35b

(B) 0.23 = Retained Earnings (Balance) 6.78b / Total Assets 29.35b

(D) 0.41 = Book Value of Equity 7.02b / Total Liabilities 16.95b

Total Rating: 1.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 76.02

1. Piotroski 5.0pt

2. FCF Yield 4.99%

3. FCF Margin 25.28%

4. Debt/Equity 0.03

5. Debt/Ebitda -1.67

6. ROIC - WACC (= 0.41)%

7. RoE 10.72%

8. Rev. Trend 90.49%

9. EPS Trend 80.26%

What is the price of BRO shares?

As of December 18, 2025, the stock is trading at USD 80.62 with a total of 1,286,486 shares traded.
Over the past week, the price has changed by +4.01%, over one month by -0.11%, over three months by -12.39% and over the past year by -21.36%.

Is BRO a buy, sell or hold?

Brown & Brown has received a consensus analysts rating of 3.58. Therefor, it is recommend to hold BRO.

Strong Buy: 3
Buy: 2
Hold: 6
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the BRO price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	93.5	16%
Analysts Target Price	93.5	16%
ValueRay Target Price	80.4	-0.2%

BRO Fundamental Data Overview December 13, 2025

Market Cap USD = 27.87b (27.87b USD * 1.0 USD.USD)
P/E Trailing = 24.0767
P/E Forward = 16.6667
P/S = 5.2087
P/B = 2.1928
P/EG = 4.41
Beta = 0.815
Revenue TTM = 5.33b USD
EBIT TTM = 1.59b USD
EBITDA TTM = 1.88b USD
Long Term Debt = 7.65b USD (from longTermDebt, last quarter)
Short Term Debt = 75.0m USD (from shortTermDebt, last quarter)
Debt = 318.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.14b USD (from netDebt column, last quarter)
Enterprise Value = 26.99b USD (27.87b + Debt 318.0m - CCE 1.19b)
Interest Coverage Ratio = 6.24 (Ebit TTM 1.59b / Interest Expense TTM 255.0m)
FCF Yield = 4.99% (FCF TTM 1.35b / Enterprise Value 26.99b)
FCF Margin = 25.28% (FCF TTM 1.35b / Revenue TTM 5.33b)
Net Margin = 18.75% (Net Income TTM 999.0m / Revenue TTM 5.33b)
Gross Margin = 49.35% ((Revenue TTM 5.33b - Cost of Revenue TTM 2.70b) / Revenue TTM)
Gross Margin QoQ = 50.62% (prev 48.76%)
Tobins Q-Ratio = 0.92 (Enterprise Value 26.99b / Total Assets 29.35b)
Interest Expense / Debt = 31.45% (Interest Expense 100.0m / Debt 318.0m)
Taxrate = 26.37% (82.0m / 311.0m)
NOPAT = 1.17b (EBIT 1.59b * (1 - 26.37%))
Current Ratio = 1.18 (Total Current Assets 8.14b / Total Current Liabilities 6.89b)
Debt / Equity = 0.03 (Debt 318.0m / totalStockholderEquity, last quarter 12.41b)
Debt / EBITDA = -1.67 (Net Debt -3.14b / EBITDA 1.88b)
Debt / FCF = -2.33 (Net Debt -3.14b / FCF TTM 1.35b)
Total Stockholder Equity = 9.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.40% (Net Income 999.0m / Total Assets 29.35b)
RoE = 10.72% (Net Income TTM 999.0m / Total Stockholder Equity 9.31b)
RoCE = 9.37% (EBIT 1.59b / Capital Employed (Equity 9.31b + L.T.Debt 7.65b))
RoIC = 7.79% (NOPAT 1.17b / Invested Capital 15.03b)
WACC = 7.38% (E(27.87b)/V(28.18b) * Re(7.20%) + D(318.0m)/V(28.18b) * Rd(31.45%) * (1-Tc(0.26)))
Discount Rate = 7.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 8.52%
[DCF Debug] Terminal Value 79.74% ; FCFE base≈1.22b ; Y1≈1.36b ; Y5≈1.78b
Fair Price DCF = 90.52 (DCF Value 30.91b / Shares Outstanding 341.4m; 5y FCF grow 12.77% → 3.0% )
EPS Correlation: 80.26 | EPS CAGR: 27.68% | SUE: 3.67 | # QB: 2
Revenue Correlation: 90.49 | Revenue CAGR: 23.05% | SUE: 2.18 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.43 | Chg30d=-0.007 | Revisions Net=-7 | Analysts=12
EPS next Year (2026-12-31): EPS=4.66 | Chg30d=-0.024 | Revisions Net=-8 | Growth EPS=+9.6% | Growth Revenue=+22.8%

Additional Sources for BRO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle